• English

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    Peer Review Program for Mental Health Medication

    This program was established to address the concerns that an increasing number of children are being prescribed antipsychotics and there is a lack of laboratory monitoring of those children.  The goal of the program is to ensure that children and adolescents receive optimal treatment in conjunction with appropriate non-pharmacologic measures in the safest manner possible.

    This program began in October 2011 and initially addressed the use of antipsychotics in Medicaid patients under five years of age.  In July 2012, it expanded to encompass children under 10 years of age. In 2013, the program began to include all children under the age of 18 years.  

    Below is the planned expansion chart of the program.  If you are requesting a Tier II or Non-Preferred antipsychotic drug for any child within the 10 to 17 year age range, the Tier II and Non-Preferred prior authorization will ONLY be approved for a LIMITED TIME.  The child will then need to be converted into the peer review program.  Based on the schedule below, you will be contacted by someone from the Peer Review Program.

    Thank you in advance for your cooperation during this transition phase.


    Patient Age (Years)


    Time Period for Prescriber to Contact Peer Review Program

    Date Prescription Will Start Denying at the Pharmacy


    Early July to Early September

    September 16, 2013


    Early August to Mid October

    October 22, 2013

    12 to 13

    Early September to Mid November

    November 19, 2013

    14 to 15

    Late September to Early December

    December 16, 2013

    16 to 17

    Mid October to Early January

    January 17, 2014


    The program works in partnership with the Mental Hygiene Administration (MHA) and the University of Maryland (UMD) School of Pharmacy and Division of Child and Adolescent Psychiatry. 

    The MMPP and the MHA hosted a webinar to discuss the PRP and answer questions regarding this program on September 15, 2011. 

    To view the power point used during the above mentioned webinar, Click here